转化医学研究
“中国核心期刊(遴选)数据库”收录期刊
“万方数据—数字化期刊群”全文入网期刊
“中国学术期刊网络出版总库”及CNKI系列数据库收录期刊
“中文科技期刊数据库”收录期刊
   优先出版

当期目录

2011年, 第1卷 第1期 出版日期:2011-01-20    下一期
选择: 合并摘要 显示/隐藏图片
综述
疾病个性化诊断相关的转化医学尝试
谢兰, 郭永, 黄国亮, 邢婉丽, 高华方, 祝令香, 王东, 张冠斌, 孙义民, 张治位, 王璨, 荆高山, 秦文彦, Keith Mitchelson, 周玉祥, 程京
转化医学研究. 2011, 1 (1): 46-68.  
摘要   PDF (8580KB)
转化医学是一种新的生物医学研究和应用模式, 强调“从床旁到实验室再到床旁”的联接, 通过将基础医学研究成果转化为临床应用的工具, 使其在疾病预防、诊断、个体化治疗和预后等各个环节发挥重要作用。清华大学利用自身在生物芯片、系统生物学、化学、微电子工程、精密仪器等方面的学科优势, 从临床医院的实际需求出发, 通过实验室研究提出解决方案, 再与生物医学企业合作将科研成果转化为产品, 最后将产品回馈应用于临床, 探索出一条从“临床需求-高校研发-企业转化-临床应用”的成功途径。经过近十年的实践, 目前已有部分科研产品获得成功转化并应用到遗传病诊断、感染性疾病诊断、自身免疫性疾病诊断、肿瘤早期诊断和转移评价、辅助生殖、生物医学仪器研制等众多领域。
相关文章 | 多维度评价
专论
转化医学的发展与未来
陈志南*
转化医学研究. 2011, 1 (1): 1-6.  
摘要   PDF (2532KB)
相关文章 | 多维度评价
The future and development of translational medicine
Zhi-nanChen*
转化医学研究. 2011, 1 (1): 1-6.  
摘要   PDF (2901KB)
相关文章 | 多维度评价
美国杜克大学的转化医学实践
杨汀,蒋典华
转化医学研究. 2011, 1 (1): 7-21.  
摘要   PDF (6390KB)
相关文章 | 多维度评价
Translational medicine at Duke University
Ting Yang,Dian-hua Jiang
转化医学研究. 2011, 1 (1): 7-29.  
摘要   PDF (6837KB)
相关文章 | 多维度评价
由HBV相关终末期肝病治疗漫谈我国转化医学发展
郑树森*,殷胜勇
转化医学研究. 2011, 1 (1): 22-29.  
摘要   PDF (3267KB)
相关文章 | 多维度评价
Translational research on the treatment of HBV related end stage liver disease in China
Shu-sen Zheng*,Sheng-yong Yin
转化医学研究. 2011, 1 (1): 22-29.  
摘要   PDF (4140KB)
相关文章 | 多维度评价
Progress of translational medicine in promoting diagnosis and treatment of renal diseases
Xiang-mei Chen*,Li Zhang
转化医学研究. 2011, 1 (1): 30-35.  
摘要   PDF (2976KB)
相关文章 | 多维度评价
转化医学促进肾脏疾病诊治的进展
陈香美*,张利
转化医学研究. 2011, 1 (1): 30-35.  
摘要   PDF (2407KB)
相关文章 | 多维度评价
综述
中国的精神分裂症转化医学研究进展
张爱萍,贺林
转化医学研究. 2011, 1 (1): 36-45.  
摘要   PDF (4650KB)
无论是从病因学还是从临床特征上看, 精神分裂症都为最复杂的一种精神疾病。然而, 经过多年对其的研究, 在发病机制方面仍未能取得突破性进展。近年来越来越受到关注的转化医学无疑将会为解决精神分裂症的临床医疗问题注入一剂强心剂, 将会着重体现在对疾病的个体化诊断与治疗、早期识别与干预、环境因素的作用与鉴别等方面, 以及用多学科交叉研究手段加深对疾病的综合治理。针对这些内容, 本文就中国精神分裂症转化医学的研究现状及今后的发展做一概述。
相关文章 | 多维度评价
Translational research for schizophrenia in Chinese
Ai-ping Zhang,Lin
转化医学研究. 2011, 1 (1): 36-45.  
摘要   PDF (4663KB)
Schizophrenia is one of the most complex psychotic disorders. Despite years of research, the fundamental nature of schizophrenia remains elusive. Recently, advances in the translational research make researchers begin to rethink the approaches they used for schizophrenia. The basic research which has been focusing on genetic mechanism is turning to integrate the need of clinical diagnosis and treatment. Research emphasis thus will be put on the study of early diagnosis, personalized treatment, environmental risks identification and prevention of schizophrenia. This review will introduce the recent advances and future studies of translational research of schizophrenia in China in these aspects.
相关文章 | 多维度评价
Advances in translational medicine for individualized diagnosis of diseases
Lan Xie,Yong Guo,Guo-liang Huang,Wan-li Xing,Hua-fang Gao,Ling-xiang Zhu,Dong Wang,Guan-bin Zhang,Yi-min Sun,Zhi-wei Zhang,Can Wang,Gao-shan Jing,Wen-yan Qin,Keith Mitchelson,Yu-xiang Zhou,Jing Cheng
转化医学研究. 2011, 1 (1): 46-68.  
摘要   PDF (10351KB)
Translational medicine is a newly emerging concept which emphasizes a link from “Bedside to Bench and back to Bedside”. It plays an important role in disease diagnosis and prevention, individualized treatment and prognosis evaluation through the translation of basic research achievements to clinical solutions. Using the advantages of biochip technology, systems biology, chemistry, micro-electronics, precision instruments and mechanology, and collaborating closely with leading clinical hospitals, Tsinghua University has established a new transformative model to link “Clinical Demands - Research in Universities or Institutions - Enterprise Transformation - Clinical Application”. After ten years of practice, great progress in translational medicine has been achieved in diverse medical fields including the diagnosis of hereditary diseases, infectious diseases, autoimmune diseases, early diagnosis for cervical cancer and risk prediction of distant metastasis for breast cancer, assisted reproductive technology and biomedical instrument development.
相关文章 | 多维度评价
Demands and challenges to the personal medicine of cancer research
Dan Li,Qi-min Zhan*
转化医学研究. 2011, 1 (1): 69-79.  
摘要   PDF (5556KB)
Personalized medicine is defined as “a form of medicine that uses information about a person's genes, proteins, and environment to prevent, diagnose, and treat disease” by the U.S. National Cancer Institute. The applications of personalized medicine in cancer is broad, including: evaluating the risk of developing a particular type of cancer and selecting screening strategies to lower this risk; Matching the right patients with the appropriate treatments that are more likely to be effective and reducing side effects by targeting treatment to each individual patient; Predicting the risk of recurrence and providing strategies to identify the patients who would benefit from adjuvant therapy. With the help of advanced knowledge of molecular oncology and development of new technologies, such as whole genome sequencing, SNPs analysis, DNA-microarray technology, proteomics by mass spectrometry and bioinformatics, patients may receive more effective tailored therapy that targeting the specific tumor. Although many challenges still remain, it is clear that personalized medicine will dramatically change the cancer therapy in the near future.
相关文章 | 多维度评价
肿瘤个体化医学研究的需求和挑战
李丹,詹启敏*
转化医学研究. 2011, 1 (1): 69-79.  
摘要   PDF (4886KB)
美国国立癌症研究中心将个体化医学定义为:“一种运用个体基因、蛋白以及环境信息来预防、诊断及治疗疾病的医药。”个体化医学在肿瘤治疗中的应用非常广泛, 其中包括:评估可能罹患某种肿瘤的风险并选择相应的筛查方法来降低这种风险;针对特定的患者给予恰当的治疗方法, 以提高效率并减少副作用;预测肿瘤复发的风险并鉴定需要辅助治疗的患者。在逐渐积累的分子肿瘤学知识以及不断进步的新技术(基因组测序、SNPs分析、DNA芯片技术、基于质谱鉴定的蛋白质组学以及生物信息学分析等)帮助下, 患者们能得到针对某种特定肿瘤的更加高效的治疗。尽管个体化医学仍面临一些挑战, 但在不久的将来它必定会极大的改善肿瘤治疗。
相关文章 | 多维度评价
评论
RNA干扰技术的临床应用需要更多的安全性研究
照日格图*
转化医学研究. 2011, 1 (1): 80-90.  
摘要   PDF (3943KB)
相关文章 | 多维度评价
16篇文章